PT1187612E - Utilizacao do riluzole para o tratamento da esclerose multipla - Google Patents
Utilizacao do riluzole para o tratamento da esclerose multiplaInfo
- Publication number
- PT1187612E PT1187612E PT00939007T PT00939007T PT1187612E PT 1187612 E PT1187612 E PT 1187612E PT 00939007 T PT00939007 T PT 00939007T PT 00939007 T PT00939007 T PT 00939007T PT 1187612 E PT1187612 E PT 1187612E
- Authority
- PT
- Portugal
- Prior art keywords
- riluzole
- treatment
- multiple sclerosis
- utilization
- benzothiazolamine
- Prior art date
Links
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 3
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 229960004181 riluzole Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99201788 | 1999-06-04 | ||
| US17432800P | 2000-01-04 | 2000-01-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1187612E true PT1187612E (pt) | 2005-05-31 |
Family
ID=56290027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00939007T PT1187612E (pt) | 1999-06-04 | 2000-06-02 | Utilizacao do riluzole para o tratamento da esclerose multipla |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1187612B1 (https=) |
| JP (1) | JP2003522121A (https=) |
| AT (2) | ATE419851T1 (https=) |
| AU (1) | AU777537B2 (https=) |
| CA (1) | CA2375874A1 (https=) |
| DE (1) | DE60017733T2 (https=) |
| ES (1) | ES2235896T3 (https=) |
| NZ (1) | NZ515685A (https=) |
| PT (1) | PT1187612E (https=) |
| SI (1) | SI1187612T1 (https=) |
| WO (1) | WO2000074676A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002519373A (ja) | 1998-07-02 | 2002-07-02 | エーザイ株式会社 | 製薬組成物及びそれらの使用 |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| IL136687A0 (en) * | 2000-06-12 | 2001-06-14 | Mor Research Applic Ltd | Pharmaceutical composition for the treatment of multiple sclerosis |
| AU2005218625A1 (en) * | 2004-03-03 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Combination therapy with glatiramer acetate and riluzole |
| ITMI20061274A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Vettori nanoparticellari lipidici contenenti riluzolo e composizioni farmaceutiche che li contengono |
| EP2228054A1 (en) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
| WO2010113225A1 (en) * | 2009-03-30 | 2010-10-07 | Yutoku Pharmaceutical Industries Co., Ltd. | Riluzole-containing transdermal patch |
| MX2017006454A (es) * | 2014-11-21 | 2018-03-23 | Biohaven Pharm Holding Co Ltd | Administracion sublingual de riluzol. |
| WO2016085998A1 (en) * | 2014-11-26 | 2016-06-02 | Medicinova, Inc. | Combination of ibudilast and riluzole and methods of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
| AU7298196A (en) * | 1995-10-25 | 1997-05-15 | Janssen Pharmaceutica N.V. | Infusions of neuroprotectants and perfluorochemicals |
| US6133258A (en) * | 1995-11-05 | 2000-10-17 | Yamanouchi Pharmaceutical Co., Ltd. | Inhibitor of kainic acid neurotoxicity and pyridothiazine derivative |
| US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
| IL119989A0 (en) * | 1997-01-10 | 1997-04-15 | Yeda Res & Dev | Pharmaceutical compositions for oral treatment of multiple sclerosis |
| JP4120713B2 (ja) * | 1997-09-04 | 2008-07-16 | 大塚製薬株式会社 | 多発性硬化症治療剤 |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
-
2000
- 2000-06-02 EP EP00939007A patent/EP1187612B1/en not_active Expired - Lifetime
- 2000-06-02 AU AU54219/00A patent/AU777537B2/en not_active Ceased
- 2000-06-02 AT AT05001476T patent/ATE419851T1/de not_active IP Right Cessation
- 2000-06-02 AT AT00939007T patent/ATE287713T1/de active
- 2000-06-02 DE DE60017733T patent/DE60017733T2/de not_active Expired - Lifetime
- 2000-06-02 EP EP05001476A patent/EP1552831B1/en not_active Expired - Lifetime
- 2000-06-02 PT PT00939007T patent/PT1187612E/pt unknown
- 2000-06-02 NZ NZ515685A patent/NZ515685A/xx not_active IP Right Cessation
- 2000-06-02 CA CA002375874A patent/CA2375874A1/en not_active Abandoned
- 2000-06-02 WO PCT/IB2000/000933 patent/WO2000074676A1/en not_active Ceased
- 2000-06-02 ES ES00939007T patent/ES2235896T3/es not_active Expired - Lifetime
- 2000-06-02 JP JP2001501213A patent/JP2003522121A/ja active Pending
- 2000-06-02 SI SI200030601T patent/SI1187612T1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE419851T1 (de) | 2009-01-15 |
| JP2003522121A (ja) | 2003-07-22 |
| ATE287713T1 (de) | 2005-02-15 |
| WO2000074676A1 (en) | 2000-12-14 |
| EP1187612B1 (en) | 2005-01-26 |
| AU5421900A (en) | 2000-12-28 |
| EP1552831B1 (en) | 2009-01-07 |
| DE60017733D1 (de) | 2005-03-03 |
| SI1187612T1 (en) | 2005-06-30 |
| EP1552831A1 (en) | 2005-07-13 |
| EP1187612A1 (en) | 2002-03-20 |
| NZ515685A (en) | 2002-12-20 |
| CA2375874A1 (en) | 2000-12-14 |
| AU777537B2 (en) | 2004-10-21 |
| DE60017733T2 (de) | 2006-01-12 |
| ES2235896T3 (es) | 2005-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| AR028512A1 (es) | Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de estas | |
| IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
| IS7214A (is) | Samsetningar sem samanstanda af sefalósporin efnasambandi og notkun þeirra við meðhöndlun á bakteríusýkingum í köttum og hundum | |
| DK1257176T3 (da) | Anvendelse af syrestabile proteaser i dyrefoder | |
| MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
| CY1110259T1 (el) | Ανοσορυθμιστης | |
| GB0125222D0 (en) | Composition for the treatment of microbial infections | |
| PT755249E (pt) | Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose | |
| FI963232L (fi) | Antimikrobisena aineena käytettävä hapotettu nitriitti | |
| BR0202519B1 (pt) | métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira. | |
| IL142900A0 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
| PT1150991E (pt) | Composicoes para o tratamento da resposta inflamatoria | |
| AU2002367172A1 (en) | 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents | |
| TR199900505T2 (https=) | ||
| CY1106234T1 (el) | Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus | |
| BR9707699A (pt) | Composições desinfetantes e processos para desinfetar superfícies | |
| PT1187612E (pt) | Utilizacao do riluzole para o tratamento da esclerose multipla | |
| NO991619L (no) | Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper | |
| PT796618E (pt) | Tratamento e profilaxia da pancreatite | |
| PT853959E (pt) | Composicao para o tratamento do amianto | |
| NZ509051A (en) | Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use | |
| ZA98420B (en) | Use of pramipexole in the treatment of restless legs syndrome. | |
| DK1133296T3 (da) | Ny terapeutisk anvendelse af nicergolin | |
| ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression |